Bioengineered artificial skin market seen reaching $4.88 billion by 2030

The Business Research Company projects the bioengineered artificial skin market will grow from $2.73 billion in 2025 to $4.88 billion by 2030, fueled by demand for burn care, chronic wound treatment and regenerative medicine. North America led the market in 2025, while Asia-Pacific is expected to grow fastest as healthcare investment and advanced therapies expand.

Why it matters: - Bioengineered artificial skin is moving from a niche medical technology into a larger wound care and regenerative medicine market. - The category could support burn treatment, chronic wound care, skin grafting and cosmetic or reconstructive procedures as demand rises. - Growth in the market signals more spending on advanced biomaterials, tissue engineering and personalized regenerative care.

What happened: - The Business Research Company published a report on the bioengineered artificial skin market on July 28, 2026. - The report projects the market will rise from $2.73 billion in 2025 to $3.07 billion in 2026. - The report forecasts the market will reach $4.88 billion by 2030. - The forecast implies a 12.4% compound annual growth rate in the near term and 12.3% growth across the forecast period. - North America held the largest market share in 2025. - Asia-Pacific is expected to post the fastest growth through 2030.

The details: - Bioengineered artificial skin is a lab-developed material designed to imitate the structure and function of human skin. - The product uses living cells with natural or synthetic components to replicate the epidermis and dermis. - Key applications include wound healing, burn treatment, skin grafts and testing for pharmaceuticals and cosmetics. - The market’s recent growth has been driven by more burn injuries, higher chronic wound rates, wider use of reconstructive surgery, progress in tissue engineering and advanced biomaterial technologies. - Future growth is tied to broader acceptance of regenerative medicine, higher demand for advanced wound care products, expanded use of stem cell therapies for skin and ongoing investment in bioprinting. - The report identifies cell-based skin substitutes, 3D bioprinted skin models, biomimetic scaffolds, regenerative wound healing and personalized skin regeneration as major trends. - The report includes coverage of Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 report package includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspot infographics, key technology analysis and updated graphics and tables. - A free sample is available through the company. - The full report is available online.

Between the lines: - The market’s growth is being pulled by both medical necessity and elective procedures, which broadens the customer base beyond burn and trauma care. - The jump in cosmetic and reconstructive surgery volume suggests demand is coming from hospitals and surgical practices, not just wound care settings. - The regional split points to a mature market in North America and a faster buildout in Asia-Pacific, where healthcare investment is increasing. - The report’s emphasis on bioprinting and cell-based substitutes suggests the field is moving toward more customized and higher-value products. - The International Society of Aesthetic Plastic Surgery reported more than 12.8 million surgical and 17.5 million non-surgical procedures worldwide in January 2023, a 19.3% increase from the previous period. - ISAPS said global plastic surgeons performed more than 14.9 million surgical and 18.8 million non-surgical operations in 2022, an 11.2% increase in total procedures.

What's next: - The market is expected to keep expanding through 2030 as regenerative medicine, stem cell therapies and bioprinting gain wider use. - Asia-Pacific’s growth trajectory will likely draw more attention from suppliers and investors targeting advanced wound care and tissue regeneration. - The Business Research Company is continuing to market the report and its related research tools to industry buyers.

The bottom line: - Bioengineered artificial skin is on a steady growth path, with rising clinical demand and new regenerative technologies pushing the market toward nearly $4.9 billion by 2030.